Relief Cardiovascular Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$12M
- Investors
-
7
Relief Cardiovascular General Information
Description
Developer of a new implantable device designed to treat congestive heart failure. The company's device monitors and modulates blood flow and is intended to reduce congestion in the heart and potentially improve outcomes for patients with this condition, enabling patients with heart failure to receive proper treatment.
Contact Information
Website
www.reliefcardio.comCorporate Office
- 3188 Airway Avenue
- Suite K1
- Costa Mesa, CA 92626
- United States
Corporate Office
- 3188 Airway Avenue
- Suite K1
- Costa Mesa, CA 92626
- United States
Relief Cardiovascular Timeline
Relief Cardiovascular Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Early Stage VC (Series A) | 26-Dec-2024 | $12M | Completed | Startup | ||
| 3. Seed Round | Completed | Startup | ||||
| 2. Spin-Off | 06-Jun-2024 | Completed | Startup | |||
| 1. Accelerator/Incubator | 26-May-2024 | Completed | Startup |
Relief Cardiovascular Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Relief Cardiovascular Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Relief Cardiovascular Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Relief Cardiovascular Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advent Life Sciences | Venture Capital | Minority | ||
| Broadview Ventures | Venture Capital | Minority | ||
| Good Growth Capital | Venture Capital | Minority | ||
| Minogue Consulting | Venture Capital | Minority | ||
| Pacific Health Investment | Venture Capital | Minority |
Relief Cardiovascular FAQs
-
When was Relief Cardiovascular founded?
Relief Cardiovascular was founded in 2022.
-
Where is Relief Cardiovascular headquartered?
Relief Cardiovascular is headquartered in Costa Mesa, CA.
-
What is the size of Relief Cardiovascular?
Relief Cardiovascular has 10 total employees.
-
What industry is Relief Cardiovascular in?
Relief Cardiovascular’s primary industry is Therapeutic Devices.
-
Is Relief Cardiovascular a private or public company?
Relief Cardiovascular is a Private company.
-
What is the current valuation of Relief Cardiovascular?
The current valuation of Relief Cardiovascular is .
-
What is Relief Cardiovascular’s current revenue?
The current revenue for Relief Cardiovascular is .
-
How much funding has Relief Cardiovascular raised over time?
Relief Cardiovascular has raised $13.5M.
-
Who are Relief Cardiovascular’s investors?
Advent Life Sciences, Broadview Ventures, Good Growth Capital, Minogue Consulting, and Pacific Health Investment are 5 of 7 investors who have invested in Relief Cardiovascular.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
